Abstract:Objective To investigate the expression level of miR-93 in cervical cancer tissues and its effects on the biological functions of the cancer cells. Methods Forty-one paired cervical cancer tissues and adjacent normal tissues were collected from Xiangya Hospital of Central South University from Jan. 2014 to Jul. 2014, and all the collected tissues had complete medical records. Using qRT-PCR, the expression of miR-93 was explored in the 41 paired cervical cancer tissues and adjacent normal tissues. miR-93 mimic was transfected into cervical cancer Hela cells to restore the expression of miR-93. The proliferation and apoptosis effects of miR-93 on Hela cells were evaluated by cell counting kit-8 (CCK-8) and flow cytometry, respectively. Moreover, the migration and invasion of transfected Hela cells were detected by Transwell chamber assay. Western blot was used to measure the expressions of EGFR and its downstream protein in the Hela cells. Results The expression of miR-93 was significantly decreased in the 41 cervical cancer tissues compared with the adjacent normal tissues [(0.048 ± 0.013) vs (0.113 ± 0.025), P =0.026]. By transfection of miR-93 mimic fragment, miR-93 expression recovered in the cervical cancer Hela cells. Overexpression of miR-93 through exogenous transfection with miR-93 mimic significantly suppressed cell proliferation (P = 0.004), induced cell apoptosis (P = 0.032), and inhibited cell migration and invasion (P = 0.003). Moreover, miR-93 overexpression of Hela cells significantly suppressed the expressions of EGFR and its downstream p-AKT (P = 0.005), while did not influence the expression of total AKT (P = 0.372), which suggested that overexpression of miR-93 significantly suppressed the EGFR/AKT signaling pathway in cervical cancer cells. Conclusions The expression of miR-93 is significantly decreased in cervical cancer tissues. Restored expression of miR-93 could suppress cell proliferation, migration and invasion, and induce cell apoptosis through, at least partially, suppression of EGFR/AKT signaling pathway.